Skip to content

The effect of midazolam on mask ventilation

The effect of midazolam premedication on mask ventilation during induction of general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002323
Enrollment
102
Registered
2017-05-12
Start date
2017-06-07
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients enrolled in this study are randomly allocated to midazolam group or control group. Total 102 patients will be enrolled. Each group consists of 51 patients. Patients of midaolam group w
maximum midazolam dose, 3 mg) intravenously at waiting area 5 minutes before transportation to an operating room. Control group patients are treated with 3 cc normal saline ar waiting area 5 minutes b

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - The patients of American Society of Anesthesiologists (ASA) class I and II who are admitted to undergo elective surgery under general anesthesia and agree to participate in this study.

Exclusion criteria

Exclusion criteria: - Aged 60 or older or under age 19 - ASA (American Society of Anesthesiologists) class = III - Current C-spine diseases or history of c-spine surgery - Planned awake intubation or rapid sequence induction due to difficulty or impossibility of mask ventilation; for example, presence of disease which can induce mechanical airway obstruction, including pharyngeal neoplasm and abscess, or morbidly obesity (BMI of = 35 kg/m2) - Risk of regurgitation and pulmonary aspiration - Sleep apnea - Craniofacial anomaly - Allergic reaction to midazolam - Chronic use of opioids, benzodiazepine, or antipsychotic medications - Pregnancy - Acute narrow angle glaucoma - Risk of muscle weakness or dyspnea such as myasthenia gravis, cerebral infarction - Patients who refuse to participate in the study or we can not receive informed consent from

Design outcomes

Primary

MeasureTime frame
Difficulty of mask ventilation (Warters grading scale)

Secondary

MeasureTime frame
Difficulty of mask ventilation (Han’s grading scale);Anxiety level; VAS score (0 - 10);Sedation level (Observer's assessment of alertness/sedation (OAA/S) scale);Neck flexion during mask ventilation;Vital signs including heart rate, blood pressure, and saturation

Countries

Korea, Republic of

Contacts

Public ContactJin-Woo Park

Seoul National University Bundang Hospital

jinul8282@gmail.com+82-31-787-7499

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026